Europe Cellulite Treatment Market 2023-2030

Europe Cellulite Treatment Market 2023-2030

Market Outlook

Triton Market Research’s report insinuates that the cellulite treatment market in Europe is expected to advance with a compound annual growth rate of 9.51% in revenue during forecast years 2023-2030. Germany, Italy, the United Kingdom, Spain, France, Nordic Countries, and the Rest of Europe are studied in the region.

In France, about 40% of the population is diagnosed with obesity, which has elevated the demand for various treatments. Moreover, there is a high population base of geriatric population. This has increased the need for cellulite reduction treatments over recent years. Further, as per industry sources, the availability of plastic surgeons has also increased over the past few years. Hence, the rising beauty consciousness is expected to increase the demand for skin procedures, thereby driving the cellulite treatment market on a growth path.

Furthermore, technological advancements have enhanced aesthetic procedures, attracting various consumers in Italy. There is also a rise in foreign patients seeking innovative skin treatments. In this regard, radiofrequency therapy has gained significant prominence. The surge in minimally invasive procedures has fueled an influx of medical tourists. Therefore, the rise in medical tourists and beauty consciousness opens new avenues for the cellulite treatment market across Italy.

Competitive Outlook

The notable companies in the cellulite treatment market include Johnson & Johnson, Bausch Health Companies Inc, Cutera Inc, Galderma SA, and Candela Medical Corporation.